Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Long-Term Debt Issuances: 2013-2014

Historic Long-Term Debt Issuances for Catalyst Pharmaceuticals (CPRX) over the last 1 years, with Mar 2014 value amounting to $5.0 million.

  • Catalyst Pharmaceuticals' Long-Term Debt Issuances was N/A to $5.0 million in Q1 2014 from the same period last year, while for Mar 2014 it was $20.0 million, marking a year-over-year change of. This contributed to the annual value of $5.0 million for FY2012, which is N/A change from last year.
  • According to the latest figures from Q1 2014, Catalyst Pharmaceuticals' Long-Term Debt Issuances is $5.0 million, which was down 0.00% from $5.0 million recorded in Q4 2013.
  • Catalyst Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $5.0 million during Q2 2013, with a 5-year trough of $5.0 million in Q2 2013.
  • Over the past 2 years, Catalyst Pharmaceuticals' median Long-Term Debt Issuances value was $5.0 million (recorded in 2014), while the average stood at $5.0 million.